X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global CAR T-Cell Therapy Companies (2024 - 2029)

Several prominent companies in the pharmaceutical and biotech sector are making significant strides in their respective fields. These firms are not only contributing to advancements in treatments and therapies but also shaping the future of healthcare. Their work ranges from developing innovative drugs to conducting groundbreaking research in oncology and other medical areas. Despite the competitive nature of the industry, these businesses continue to make noteworthy progress, demonstrating their commitment to improving health outcomes worldwide.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Global CAR T-Cell Therapy Market

This report lists the top Global CAR T-Cell Therapy companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global CAR T-Cell Therapy industry.

  1. Novartis

  2. Bristol-Myers Squibb

  3. Johnson & Johnson

  4. Sorrento Therapeutics

  5. Gilead Sciences

*Disclaimer: Top companies sorted in no particular order

Global CAR T-Cell Therapy Market Major Players

Global CAR T-Cell Therapy Market Concentration

Global CAR T-Cell Therapy  Market Concentration

Global CAR T-Cell Therapy Company List

                              • Novartis AG

                              • Bristol-Myers Squibb Company

                              • Gilead Sciences, Inc. (Kite Pharma)

                              • Johnson & Johnson

                              • Eli Lilly and Company

                              • Sorrento Therapeutics, Inc.

                              • ACROBiosystems

                              • Celyad Oncology

                              • Sangamo Therapeutics, Inc.

                              • Servier Laboratories

                              • Noile-Immune Biotech, Inc.

                              • Miltenyi Biotec


                          Specific to Global CAR T-Cell Therapy Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Competitive Landscape Report Includes

                          Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

                          Global CAR T-Cell Therapy Market Companies Summary

                          The CAR T-cell therapy industry has been significantly impacted by the COVID-19 pandemic, leading to a decrease in patients undergoing therapy due to the high risk of poor outcomes. However, with the introduction of vaccines and easing of lockdown restrictions, research and development activities have resumed, and patient visits have increased, indicating potential growth in the market. The industry's growth can be attributed to the increasing burden of cancer and the rise in research and development to develop CAR T-cell therapy. The anticipated increase in cancer cases is expected to drive the demand for this therapy. Additionally, increasing research and development activities are contributing to market growth. Several firms in the CAR T-cell therapy market have reported significant developments, driving the demand for CAR T-cell therapies and contributing to market growth. However, the high cost of developing CAR T-cell therapy is a major factor hindering market growth. The market is moderately competitive with several global and international players. These key players are adopting various growth strategies, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions, to enhance their market presence.

                          Explore More

                          Global CAR T-Cell Therapy Companies - Table of Contents

                          1. 1. COMPETITIVE LANDSCAPE

                            1. 1.1 Company Profiles

                              1. 1.1.1 Novartis AG

                              2. 1.1.2 Bristol-Myers Squibb Company

                              3. 1.1.3 Gilead Sciences, Inc. (Kite Pharma)

                              4. 1.1.4 Johnson & Johnson

                              5. 1.1.5 Eli Lilly and Company

                              6. 1.1.6 Sorrento Therapeutics, Inc.

                              7. 1.1.7 ACROBiosystems

                              8. 1.1.8 Celyad Oncology

                              9. 1.1.9 Sangamo Therapeutics, Inc.

                              10. 1.1.10 Servier Laboratories

                              11. 1.1.11 Noile-Immune Biotech, Inc.

                              12. 1.1.12 Miltenyi Biotec

                            2. *List Not Exhaustive

                          Global CAR T-Cell Therapy Companies FAQs

                          Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson, Sorrento Therapeutics, Inc. and Gilead Sciences, Inc. (Kite Pharma) are the major companies operating in the Global CAR T-Cell Therapy Market.

                          CAR-T Cell Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)